Eledon Pharmaceuticals shares owned by Ingalls & Snyder
Quarter-by-quarter ownership of Eledon Pharmaceuticals (ELDN) shares owned by Ingalls & Snyder
from 13F filings
Historical chart of Ingalls & Snyder investment in Eledon Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Eledon Pharmaceuticals held by Ingalls & Snyder consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Eledon Pharmaceuticals by Ingalls & Snyder
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $93k | 52k | 1.79 |
2023-09-30 | $71k | 52k | 1.37 |
2023-06-30 | $70k | 51k | 1.38 |
2023-03-31 | $120k | 51k | 2.36 |
2022-12-31 | $116k | 51k | 2.28 |
2022-09-30 | $141k | 51k | 2.76 |
2022-06-30 | $125k | 51k | 2.44 |
2022-03-31 | $202k | 51k | 3.95 |
2021-12-31 | $226k | 51k | 4.42 |
2021-09-30 | $316k | 51k | 6.18 |
2021-06-30 | $405k | 51k | 7.92 |
2021-03-31 | $547k | 51k | 10.69 |